FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366827056> ?p ?o ?g. }

• W4366827056 abstract "Abstract Background Tuberculosis remains a leading infectious cause of death in resource-limited settings. Effective treatment is the cornerstone of tuberculosis control, reducing mortality, recurrence and transmission. Supporting treatment adherence through facility-based observations of medication taking can be costly to providers and patients. Digital adherence technologies (DATs) may facilitate treatment monitoring and differentiated care. The ASCENT-Ethiopia study is a three-arm cluster randomised trial assessing two DATs with differentiated care for supporting tuberculosis treatment adherence in Ethiopia. This study is part of the ASCENT consortium, assessing DATs in South Africa, the Philippines, Ukraine, Tanzania and Ethiopia. The aim of this study is to determine the costs, cost-effectiveness and equity impact of implementing DATs in Ethiopia. Methods and design A total of 78 health facilities have been randomised (1:1:1) into one of two intervention arms or a standard-of-care arm. Approximately 50 participants from each health facility will be enrolled on the trial. Participants in facilities randomised to the intervention arms are offered a DAT linked to the ASCENT adherence platform for daily adherence monitoring and differentiated response for those who have missed doses. Participants at standard-of-care facilities receive routine care. Treatment outcomes and resource utilisation will be measured for each participant. The primary effectiveness outcome is a composite index of unfavourable end-of-treatment outcomes (lost to follow-up, death or treatment failure) or treatment recurrence within 6 months of end-of-treatment. For the cost-effectiveness analysis, end-of-treatment outcomes will be used to estimate disability-adjusted life years (DALYs) averted. Provider and patient cost data will be collected from a subsample of 5 health facilities per study arm, 10 participants per facility ( n = 150). We will conduct a societal cost-effectiveness analysis using Bayesian hierarchical models that account for the individual-level correlation between costs and outcomes as well as intra-cluster correlation. An equity impact analysis will be conducted to summarise equity efficiency trade-offs. Discussion Trial enrolment is ongoing. This paper follows the published trial protocol and describes the protocol and analysis plan for the health economics work package of the ASCENT-Ethiopia trial. This analysis will generate economic evidence to inform the implementation of DATs in Ethiopia and globally. Trial registration Pan African Clinical Trial Registry (PACTR) PACTR202008776694999. Registered on 11 August 2020, https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12241 ." @default.
• W4366827056 created "2023-04-25" @default.
• W4366827056 creator A5006855967 @default.
• W4366827056 creator A5014274469 @default.
• W4366827056 creator A5014550707 @default.
• W4366827056 creator A5020117771 @default.
• W4366827056 creator A5021216969 @default.
• W4366827056 creator A5024624340 @default.
• W4366827056 creator A5026823919 @default.
• W4366827056 creator A5031438258 @default.
• W4366827056 creator A5035602036 @default.
• W4366827056 creator A5044356857 @default.
• W4366827056 creator A5046108489 @default.
• W4366827056 creator A5056585679 @default.
• W4366827056 creator A5060388654 @default.
• W4366827056 creator A5063304120 @default.
• W4366827056 creator A5067773776 @default.
• W4366827056 creator A5072938123 @default.
• W4366827056 creator A5077644295 @default.
• W4366827056 creator A5089532533 @default.
• W4366827056 date "2023-04-24" @default.
• W4366827056 modified "2023-10-18" @default.
• W4366827056 title "Evaluating the equity impact and cost-effectiveness of digital adherence technologies with differentiated care to support tuberculosis treatment adherence in Ethiopia: protocol and analysis plan for the health economics component of a cluster randomised trial" @default.
• W4366827056 cites W155390068 @default.
• W4366827056 cites W1986060112 @default.
• W4366827056 cites W2007344889 @default.
• W4366827056 cites W2051152597 @default.
• W4366827056 cites W2086503315 @default.
• W4366827056 cites W2093006581 @default.
• W4366827056 cites W2100383609 @default.
• W4366827056 cites W2101104998 @default.
• W4366827056 cites W2104590203 @default.
• W4366827056 cites W2112347815 @default.
• W4366827056 cites W2113309897 @default.
• W4366827056 cites W2118758782 @default.
• W4366827056 cites W2131309922 @default.
• W4366827056 cites W2139627330 @default.
• W4366827056 cites W2150539032 @default.
• W4366827056 cites W2169880351 @default.
• W4366827056 cites W2286756681 @default.
• W4366827056 cites W2337449659 @default.
• W4366827056 cites W2413906814 @default.
• W4366827056 cites W2542986468 @default.
• W4366827056 cites W2557867537 @default.
• W4366827056 cites W2756268514 @default.
• W4366827056 cites W2762446530 @default.
• W4366827056 cites W2764297291 @default.
• W4366827056 cites W2784272297 @default.
• W4366827056 cites W2805491393 @default.
• W4366827056 cites W2806899454 @default.
• W4366827056 cites W2810683857 @default.
• W4366827056 cites W2888941363 @default.
• W4366827056 cites W2896055019 @default.
• W4366827056 cites W2950445808 @default.
• W4366827056 cites W2963353941 @default.
• W4366827056 cites W2965657966 @default.
• W4366827056 cites W2991420412 @default.
• W4366827056 cites W3010313261 @default.
• W4366827056 cites W3013507461 @default.
• W4366827056 cites W3032370132 @default.
• W4366827056 cites W3095783356 @default.
• W4366827056 cites W3110634754 @default.
• W4366827056 cites W3110876272 @default.
• W4366827056 cites W3138778433 @default.
• W4366827056 cites W3157487954 @default.
• W4366827056 cites W3162694864 @default.
• W4366827056 cites W3211611236 @default.
• W4366827056 cites W3215005393 @default.
• W4366827056 cites W4211098515 @default.
• W4366827056 cites W4220656655 @default.
• W4366827056 cites W4310779941 @default.
• W4366827056 doi "https://doi.org/10.1186/s13063-023-07289-x" @default.
• W4366827056 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37095533" @default.
• W4366827056 hasPublicationYear "2023" @default.
• W4366827056 type Work @default.
• W4366827056 citedByCount "0" @default.
• W4366827056 crossrefType "journal-article" @default.
• W4366827056 hasAuthorship W4366827056A5006855967 @default.
• W4366827056 hasAuthorship W4366827056A5014274469 @default.
• W4366827056 hasAuthorship W4366827056A5014550707 @default.
• W4366827056 hasAuthorship W4366827056A5020117771 @default.
• W4366827056 hasAuthorship W4366827056A5021216969 @default.
• W4366827056 hasAuthorship W4366827056A5024624340 @default.
• W4366827056 hasAuthorship W4366827056A5026823919 @default.
• W4366827056 hasAuthorship W4366827056A5031438258 @default.
• W4366827056 hasAuthorship W4366827056A5035602036 @default.
• W4366827056 hasAuthorship W4366827056A5044356857 @default.
• W4366827056 hasAuthorship W4366827056A5046108489 @default.
• W4366827056 hasAuthorship W4366827056A5056585679 @default.
• W4366827056 hasAuthorship W4366827056A5060388654 @default.
• W4366827056 hasAuthorship W4366827056A5063304120 @default.
• W4366827056 hasAuthorship W4366827056A5067773776 @default.
• W4366827056 hasAuthorship W4366827056A5072938123 @default.
• W4366827056 hasAuthorship W4366827056A5077644295 @default.
• W4366827056 hasAuthorship W4366827056A5089532533 @default.
• W4366827056 hasBestOaLocation W43668270561 @default.
• W4366827056 hasConcept C142724271 @default.
• W4366827056 hasConcept C160735492 @default.
• W4366827056 hasConcept C162324750 @default.
• W4366827056 hasConcept C2781069245 @default.

• next